CI study of the water dimer potential surface

O Matsuoka, E Clementi, M Yoshimine - The Journal of Chemical …, 1976 - pubs.aip.org
… wavefunction and obtained a value of ± O. 73 kcal/mole as an … This does give a strong support
to our error estimate of ± O. 2 … the accuracy of our CI results (± O. 2 kcal/mole mentioned in …

Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform

K Takazawa, N Tanaka, M Fujita, O Matsuoka… - …, 1998 - Am Heart Assoc
To evaluate the clinical application of the second derivative of the fingertip photoplethysmogram
waveform, we performed drug administration studies (study 1) and epidemiological …

[HTML][HTML] Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a …

…, H Kim, A Kiyosue, K Matoba, O Matsuoka… - The Lancet Diabetes & …, 2020 - thelancet.com
Background Given the unique phenotype of type 2 diabetes in Japanese patients, novel
therapies such as oral semaglutide require evaluation in this population. PIONEER 9 aimed to …

CT and MR imaging of cerebral tuberous sclerosis

…, T Tashiro, M Shakudo, K Kohno, O Matsuoka… - Brain and …, 1998 - Elsevier
Tuberous sclerosis is a heredofamilial neurocutaneous syndrome, or phakomatosis, with
multisystem involvement including the brain, kidney, skin, retina, heart, lung, and bone. The …

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre …

K Kaku, S Inoue, O Matsuoka, A Kiyosue… - Diabetes, Obesity …, 2013 - Wiley Online Library
Aim Dapagliflozin is a selective sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitor under
development as a treatment for type 2 diabetes mellitus ( T2DM ). This study assessed the …

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled …

…, H Kim, A Kiyosue, O Matsuoka, O Miho… - The Lancet Diabetes & …, 2020 - thelancet.com
Background New glucose-lowering medications need to be investigated in east Asian
populations, as the clinical characteristics of type 2 diabetes differ between western and east …

Arterial stiffness independently predicts cardiovascular events in an elderly community—Longitudinal Investigation for the Longevity and Aging in Hokkaido County …

O Matsuoka, K Otsuka, S Murakami, N Hotta… - Biomedicine & …, 2005 - Elsevier
We investigated the predictive value of arterial stiffness to assess cardiovascular risk in elderly
community-dwelling people by means of a multivariate Cox model. In 298 people older …

Ultra-thin passivating film induced by vinylene carbonate on highly oriented pyrolytic graphite negative electrode in lithium-ion cell

O Matsuoka, A Hiwara, T Omi, M Toriida… - Journal of Power …, 2002 - Elsevier
We investigated the influence of vinylene carbonate, as an additive molecule, on the
decomposition phenomena of electrolyte solution [ethylene carbonate (EC)—ethyl methyl …

Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation

…, H Shintaku, H Hattori, O Matsuoka… - Annals of Neurology …, 2001 - Wiley Online Library
A longitudinal study of cranial magnetic resonance imaging (MRI) was carried out in 23
patients with mucopolysaccharidoses (MPS); 1 each of types IH, VI, and VII; 2 of type IS; 10 of …

AFM observation of double 4-rings on zeolite LTA crystals surface

S Sugiyama, S Yamamoto, O Matsuoka… - Microporous and …, 1999 - Elsevier
Atomic force microscopy (AFM) revealed two features of the surface structure of Linde type
A (LTA) crystals for the first time. The first is that LTA crystals contained fine pyramidal …